Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01766856 · ClinicalTrials.gov registry record
Eustachian Tube Function and Myringoplasty/Tympanoplasty
A clinical trial, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- 19
- Enrollment target
NCT01766856: Clinical Trial study, sponsored by University of Pittsburgh.
NCT01766856 is a clinical trial that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01766856 was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This study will determine whether the likely success of closing a hole in the eardrum can be predicted by testing Eustachian tube function. The Eustachian tube is a natural tube that connects the back of the nose with the middle ear. When a person goes up in an airplane and their ears "pop" or when one yawns and their ears "pop", that is the Eustachian tube opening. The Eustachian tube is responsible for keeping the air pressure in the middle ear the same as in the environment and keeping the middle ear free of fluid. It is thought that in children with middle-ear disease, the muscles that open the Eustachian tube do not work very well; this seems to get better in many children as they get older. It is thought that poor Eustachian tube function is the cause of failures when holes in the eardrum are patched and also for the recurrence of fluid in the middle-ear. The primary goal of this study is to see whether it can be predicted, based on testing Eustachian tube function before surgery, whether patching the eardrum will be successful and whether fluid will come back in the ear after it is patched.
Primary Outcome
Evidence of intact eardrum at 12 months after surgery
Interventions
- OTHER Eustachian tube function testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-11 |
| Est. Completion | 2017-11-02 |
Why NCT01766856 stopped before completion
NCT01766856 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Eustachian tube function testing is the first listed.
NCT01766856 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01766856 about?
NCT01766856 is a clinical study titled "Eustachian Tube Function and Myringoplasty/Tympanoplasty". This study will determine whether the likely success of closing a hole in the eardrum can be predicted by testing Eustachian tube function. The Eustachian tube is a natural tube that connects the back of the nose with the middle ear. When a person goes up in an airplane and their ears "pop" or when ...
What is the current status of trial NCT01766856?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2012-11. Estimated completion is 2017-11-02.
What interventions are being tested in trial NCT01766856?
The interventions under investigation include: Eustachian tube function testing (OTHER).
Who is sponsoring clinical trial NCT01766856?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia